- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06443814
Multicenter Trial of Meditation and Health Education for Cardiometabolic Disease in Black Women
A Clinical Trial on the Prevention of Coronary Artery Disease, Insulin Resistance and Hyperlipidemia in Black Women With Meditation and Health Education
Study Overview
Status
Intervention / Treatment
Detailed Description
This was a randomized controlled trial that compared the effects of stress reduction using the Transcendental Meditation technique (TM) to a health education (HE) group in 201 African American women >55 years with CVD or at high CVD risk over a one-year intervention and follow-up period.
All participants were randomly allocated to either of two behavioral treatment groups-1) the Transcendental Meditation (TM) program or 2) a health education (HE) program of healthy diet, exercise and substance use control. Women participants were recruited, tested, and instructed at two sites:139 were recruited and randomized in Washington, DC and 61 in Atlanta, GA. Outcome measures were carotid intima-media thickness (IMT), insulin resistance, serum lipids, blood pressure and lifestyle (diet, exercise, substance use).
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
District of Columbia
-
Washington, DC, District of Columbia, United States
- Howard University Heart Center
-
-
Georgia
-
Atlanta, Georgia, United States
- Morehouse School of Medicine - Morehouse Medical Associates
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- African American women,
- 55 years or older with at least one of the five cardiovascular conditions (below):
Either/or:
- coronary heart disease or
- positive coronary angiography or
- previous MI or
- coronary revascularization or
- percutaneous transluminal coronary angioplasty (PTCA).
OR a risk factor assessment score of at least two points based on the Framingham study/ATP III report. Risk factors included diabetes, high systolic or diastolic BP, high cholesterol, high LDL-low HDL or smoking.
Exclusion Criteria:
Recent (last 3 months):
- myocardial infarction
- unstable angina
- coronary artery by-pass grafting (CABG)
- percutaneous transluminal coronary angioplasty (PTCA)
- stroke within the preceding three months
- carotid artery endarterectomy
- atrial fibrillation
- second or third degree AV block
- heart failure
- clinically significant valvular heart disease
- major psychiatric disorders,
- current alcohol/dependency disorder
- other drug abuse dependency disorder
- non-cardiac life-threatening illness
- participating in a formal stress management program
- plans to move out of the study area or travel extensively
- unwillingness to accept randomization into any study group.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Transcendental Meditation
The TM technique is practiced for 20 minutes twice a day.
Participants were instructed by a certified teacher in 7-step course to learn how to meditate according to previously standardized and validated procedures.
|
TM was taught in a standardized and validated format as a simple, natural mental technique practiced for 20 minutes twice a day (morning and evening) to give rest and relaxation to mind and body.
TM was taught by a certified instructor and a 7-step process taking place over 4 consecutive days after which the meditator can practice at home twice a day.
Other Names:
|
|
Active Comparator: Health Education
The health education group was matched for instructor time and attention to the TM group.
The classroom-based health education group received AHA-based guidelines for healthy diet, exercise and control of substance use.
No stress management techniques are taught in this group.
|
This was a didactic classroom-based control which educates the patient on adapting a healthier lifestyle through proper diet, exercise, and moderating substance usage according to current AHA guidelines.
This intervention does not include a stress management component.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Carotid intima-media thickness (CIMT)
Time Frame: 0 and 12 months
|
B mode ultrasound measurement of carotid artery wall thickness
|
0 and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical Activity
Time Frame: 0, 4 and 12 months
|
Exercise --using the Folsom Physical Activity Questionaire
|
0, 4 and 12 months
|
|
Hemoglobin A1c
Time Frame: Before and after 12 months of intervention and follow up
|
Hb1c as surrogate endpoint for diabetes
|
Before and after 12 months of intervention and follow up
|
|
Insulin resistance
Time Frame: 0 and 12 months
|
HOMA index utilizing glucose and insulin levels at timed intervals
|
0 and 12 months
|
|
Lipids
Time Frame: 0 and 12 months
|
fasting levels of serum LDL, HDL, TC, TG
|
0 and 12 months
|
|
Blood pressure
Time Frame: 0, 4 and 12 months
|
measured three times with a mercury sphygmomanometer 5 minutes apart and last two reading averaged
|
0, 4 and 12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Linda Heaton, Institute for Natural Medicine and Prevention, Maharishi International University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1P50AT000082-03 (U.S. NIH Grant/Contract)
- 1P50AT000082 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome
-
Sun Yat-sen UniversityNot yet recruitingMetabolic Syndrome Risk Factors | Metabolic Syndrome (MetS)China
-
Meihua JiThe Luhe Teaching Hospital of the Capital Medical UniversityRecruiting
-
Meihua JiThe Luhe Teaching Hospital of the Capital Medical UniversityEnrolling by invitationMetabolic Syndrome (MetS)China
-
National University Health System, SingaporeRecruitingMetabolic Syndrome | Metabolic Syndrome (MetS)Singapore
-
University of KhartoumMinistry of Higher Education and Scientific Research, Republic of SudanCompletedMetabolic Syndrome in Postmenopausal FemalesSudan
-
Hacettepe UniversityCompletedMetabolic Syndrome | Metabolic Syndrome Obesity | Metabolic Syndrome ParametersTurkey
-
Universidad de los Andes, ChileCompleted
-
University of Missouri-ColumbiaRecruitingGlucose Metabolism Disorders | Metabolic Syndrome | Metabolic Syndrome, Protection AgainstUnited States
-
Mayo ClinicCompleted
-
SanofiBristol-Myers SquibbCompletedMetabolic Syndrome xUnited States
Clinical Trials on Transcendental Meditation
-
Duke UniversityCompletedBurnout, Professional | Stress, PsychologicalUnited States
-
Maharishi International UniversityRecruitingSocial DynamicsUnited States
-
University of ArizonaDavid Lynch FoundationWithdrawnDepression | Burnout, Professional | Stress, Psychological | Job Stress
-
Maharishi International UniversityMedical College of WisconsinCompletedCardiovascular Disease | Coronary Heart DiseaseUnited States
-
Maharishi International UniversityColumbia UniversityUnknownCoronary Artery DiseaseUnited States
-
Sheba Medical CenterWithdrawnAttention Deficit Disorder With Hyperactivity | Attention-Deficit Disorder in Adolescence
-
Medical University of GrazCompletedCardiovascular Diseases | Vascular Diseases | Stress, PsychologicalAustria
-
The Center for Clinical and Cosmetic ResearchDavid Lynch FoundationCompletedBurnout | Insomnia | Well BeingUnited States
-
Marie LoiselleLoyola University ChicagoCompletedDepression | Burnout, Professional | Insomnia | Resilience | Perceived StressUnited States
-
Queen Mary University of LondonTerminated